本页面由Tiger Trade Technology Pte. Ltd.提供服务

Moderna, Inc.

79.76
+7.2610.01%
盘后80.420.6602+0.83%19:59 EDT
成交量:1,411.20万
成交额:11.06亿
市值:315.00亿
市盈率:-9.80
高:81.40
开:73.71
低:73.68
收:72.50
52周最高:81.40
52周最低:22.28
股本:3.95亿
流通股本:3.63亿
量比:1.40
换手率:3.88%
股息:- -
股息率:- -
每股收益(TTM):-8.1400
每股收益(LYR):-7.2600
净资产收益率:-36.56%
总资产收益率:-13.09%
市净率:4.25
市盈率(LYR):-10.99

数据加载中...

2026/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

关联方拟减持公告

Form 144 | Moderna, Inc. 高管 Stephen Hoge 拟减持53,336股普通股,拟套现约2,581,462.40美元
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/05

重要事件披露

Form 8-K - Current report
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 | Moderna高管Hoge Stephen拟减持160009股,总价约781.5万美元
2026/02/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/13

重要事件披露

Form 8-K - Current report
2026/02/11

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/05

重要事件披露

Form 8-K - Current report